Rentokil Initial Reports Strong H2 Growth and Progress on North America Strategy

Rentokil reports accelerating H2 growth, strong cash flow, and progress on its localised North America strategy, though headwinds from legacy issues remain.

5 March 2026by Joshua Thompson6 min read43 views

This article covers information on Rentokil Initial PLC.

LON:RTO

H2 organic growth accelerates: Rentokil Initial’s 2025 results in plain English

Rentokil Initial has delivered a much-needed uptick in momentum through 2025, with the second half doing the heavy lifting. Group Organic Revenue Growth – that’s sales growth excluding M&A and currency – improved to 3.5% in H2 (H1: 1.6%), helping the year land at 2.6%.

Management is leaning into a more local, multi-brand model in North America and a simplified integration plan. Cash generation was excellent, leverage stepped down, and guidance for 2026 is “in line with market expectations”. There is still an elephant in the room – the legacy termite provision – but the trajectory elsewhere is heading the right way.

Key numbers you need to know

Metric (continuing operations)	FY2025 result
Revenue	$6,908m (+4.4% reported; +3.8% at constant currency)
Organic Revenue Growth	2.6% (H2: 3.5%; H1: 1.6%)
Adjusted Operating Profit	$1,070m (+5.4%)
Adjusted Operating Margin	15.5% (+0.3%pts); North America 17.4% (+0.4%pts)
Free Cash Flow	$615m (+24.5%); conversion 98%
Net debt and leverage	$3,650m; Net debt:EBITDA 2.6x (from 2.9x)
Dividend per share	12.39c (+3.0%); final 8.24c (+4.6%)
Q4 North America Pest Control Services organic growth	2.6% (Q3: 1.8%; H1: 0.1%)
Termite provision (closing)	$384m; cash claims paid in 2025 $95m (similar expected in 2026)

Note: From 1 January 2025, Rentokil reports in US dollars and now presents two segments – North America and International – with prior-year comparatives restated.

North America strategy: 30 brands, c.800 branches, and a simpler integration

North America is the battleground. The evolved approach is less about one monolithic brand and more about using strong national, regional and local names to tap highly localised demand. Management now plans to retain about 30 brands covering over 90% of revenue and to build a network of around 800 branches by the end of 2026, including roughly 220 small “satellite” branches that push service teams closer to customers.

Lead generation and marketing sharpened: residential lead flow rose 7.1% in H2 with a double-digit reduction in cost per lead, helped by better SEO, local web pages and content optimised for AI search.
Sales execution: sales accountability moved back into branches; a summer door-to-door pilot ran in 25 territories with plans for 40 in 2026.
Integration reset: rather than forcing a single IT system everywhere, a new branch BI scorecard lets multiple systems run while giving field leaders consistent KPIs and actions.
People and retention: customer retention nudged up to 80.5%; colleague retention improved to 82.2%.
Efficiency: $25m of savings delivered in 2025; on track for around $100m cost reduction by 2027, underpinning a North America Operating Profit margin target above 20% in 2027.

Why it matters: Q4 North America Organic Revenue Growth reached 3.6%, with Pest Control Services at 2.6%. The sequential improvement suggests the playbook is gaining traction. If the branch expansion and multi-brand plan keep conversion high while the BI tooling de-risks integration, the business can grow without tripping over its own shoelaces.

International keeps pulling its weight

The International segment quietly delivered another solid year: Revenue up 4.8% (at constant currency), Organic Revenue Growth 3.0%, and Adjusted Operating Profit up 5.7% with a 19.8% margin. The UK, Spain and Portugal stood out, with Indonesia and India also strong. Pacific was softer due to weather. This stability matters – it buys time for North America to re-accelerate without dragging group margins.

Share𝕏 in

Investing
Polar Capital Technology Trust Reports 102% NAV Growth in Stellar Fiscal Year
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Investing

Tagged

Last updated

5 July 2026

Star Rating

No ratings yet

Cash, debt and dividend: tidy work

Free Cash Flow of $615m and a 98% conversion rate were ahead of guidance, supported by disciplined working capital and some one-off benefits including property disposals. Net debt fell to $3,650m despite an adverse $181m translation effect, taking leverage down to 2.6x. Liquidity headroom at year end was $2.6bn, and on 2 March 2026 the company redeemed its €500m 0.875% notes due May 2026.

Dividends are gently rising in line with the progressive policy: the full-year pay-out is 12.39c, with a recommended final of 8.24c.

Termite provision: the overhang explained

Rentokil increased its legacy termite warranty provision by $201m in 2025 to $384m, including an additional $122m in H2. The drivers were a higher number of litigated claims versus 2024 (still below acquisition levels), higher average costs per claim as the company resolves issues proactively, settlements of larger legacy commercial cases, and a higher long-term inflation assumption of 3.2%.

Cash paid for claims was $95m in 2025 and is expected to be at a similar level in 2026. This provision depressed statutory profit (Operating Profit fell to $584m), even as Adjusted Operating Profit rose. In short: it’s a manageable cash drain at current levels, but it remains the key risk factor to monitor.

Innovation and data: useful tailwinds, not hype

There’s real operational tech here. Gemini for Google Workspace has been rolled out to about 63,400 colleagues; an in-house “RAT-GPT” platform has over 100 AI agents in development, including lead prioritisation and a hands-free field assistant pilot in the US. More than 600,000 PestConnect devices are now installed, and 4.1 million images were processed through a cloud AI tool in 2025. The 2026 focus is on advancing these agents to drive productivity further.

2026 outlook and guidance

Despite some January weather disruption in North America and broader geopolitical uncertainty, management expects FY2026 results to be in line with market expectations. Technical guidance points to:

Adjusted interest cost of about $210m-$220m (including $5m-$10m of hyper-inflation impacts).
Capex (ex-lease) of $190m-$200m.
Cash tax payments of $110m-$125m.
One-off and adjusting cash items of around $80m-$85m.
M&A spend of around $200m.

My take: progress you can bank, risks you can measure

Positives first. H2 momentum, particularly in North America, is the headline. A 3.6% Q4 organic print in North America (and 2.6% in Pest Control Services) suggests the operational tweaks are working. Margin expanded, cash flow was excellent, and leverage moved down. The decision to keep more local brands and ramp up smaller branches looks customer-centric and data-backed, which should support retention and lead conversion.

On the flip side, the termite legacy remains the swing factor for statutory earnings and a continuing cash call. Interest costs are higher than they were, and the North America transformation still has execution risk, even with a simplified systems approach.

Overall, 2025 reads like a reset year that finished strongly. If Rentokil sustains North America organic growth, converts more of those efficiency plans into dollars, and keeps claim outflows steady, the 2027 target of a North America margin above 20% looks achievable – and that would be a material upgrade to the investment case.

What to watch in 2026

North America Pest Control Services organic growth staying on a 2%+ run-rate and improving through peak season.
Branch rollout to around 220 satellites and tangible lead/retention benefits from the multi-brand strategy.
Delivery of cost savings on the path to c.$100m by 2027 and evidence of further margin expansion.
Termite cash outflows around $95m and any further movements in the provision.
International momentum in the UK, Southern Europe, India and Indonesia holding above 3% organic.
Cash discipline maintained – leverage trending below 2.6x while funding c.$200m of bolt-on M&A.

Final word

Encouraging H2 execution, stronger cash generation and a clearer, simpler North America plan. The termite issue still clouds the statutory P&L, but it’s quantified and, for now, cash-manageable. With a new CEO stepping in mid-March and a roadmap to >20% North America margin in 2027, the next 12 months are about proving this playbook at scale.